Initiating angiotensin II at lower vasopressor doses in vasodilatory shock: an exploratory post-hoc analysis of the ATHOS-3 clinical trial

BACKGROUND: High dose vasopressors portend poor outcome in vasodilatory shock. We aimed to evaluate the impact of baseline vasopressor dose on outcomes in patients treated with angiotensin II (AT II). METHODS: Exploratory post-hoc analysis of the Angiotensin II for the Treatment of High-Output Shock...

Descripción completa

Detalles Bibliográficos
Autores principales: Wieruszewski, Patrick M., Bellomo, Rinaldo, Busse, Laurence W., Ham, Kealy R., Zarbock, Alexander, Khanna, Ashish K., Deane, Adam M., Ostermann, Marlies, Wunderink, Richard G., Boldt, David W., Kroll, Stew, Greenfeld, Chuck R., Hodges, Tony, Chow, Jonathan H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10163684/
https://www.ncbi.nlm.nih.gov/pubmed/37147690
http://dx.doi.org/10.1186/s13054-023-04446-1

Ejemplares similares

Ejemplares similares